Sartorius Stedim Biotech S.A. (EPA: DIM)
France flag France · Delayed Price · Currency is EUR
175.00
+6.40 (3.80%)
Nov 22, 2024, 5:35 PM CET

Sartorius Stedim Biotech Company Description

Sartorius Stedim Biotech S.A. engages in the production and sale of instruments and consumables for the biopharmaceutical industry worldwide.

The company offers various products, such as cell lines; cell culture media; bioreactors; advanced therapies; and a range of products for separation, purification, and concentration processes, as well as products and systems for storage and transportation of intermediate and finished biological products.

It also provides cell cultivation, fermentation, separation, purification, and fluid management services; biolayer interferometry instruments; microbiology enumeration, sterility testing, and air monitoring instruments; pipette products; sensors and analyzers; biomolecule analysis tools; flow cytometry; batch and intensified chromatography systems; lab data and fleet management software; live cell imaging and analysis; surface plasmon resonance solutions; and weighing products.

In addition, the company offers data analytics software for modeling and optimizing processes of biopharmaceutical development and production; process automation platform and software; and develops and produces transfection, as well as other DNA/RNA delivery reagents and plasmid DNA.

It serves manufacturers of medications, vaccines, foods, and chemicals, as well as research and development laboratories.

The company was incorporated in 1978 and is headquartered in Aubagne, France. As of December 31, 2023, Sartorius Stedim Biotech S.A. operates as a subsidiary of Sartorius AG.

Sartorius Stedim Biotech S.A.
Sartorius Stedim Biotech logo
Country France
Founded 1978
Industry Medical Instruments & Supplies
Sector Healthcare
Employees 10,662
CEO Rene Faber

Contact Details

Address:
Zone Industrielle Les Paluds
Aubagne, 13781
France
Phone 33 4 42 84 56 00
Website sartorius.com

Stock Details

Ticker Symbol DIM
Exchange Euronext Paris
Fiscal Year January - December
Reporting Currency EUR
ISIN Number FR0013154002
SIC Code 3826

Key Executives

Name Position
Dr. Rene Faber Chief Executive Officer and DIrector
Rainer Lehmann Chief Financial Officer and Member of Executive Board
Petra Muller Head of Investor Relations
Petra Kirchhoff Head of Corporate Communications and IR
Olivier Guitard Head of Controlling BPS